BioNTech SE BNTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:56 PM EDT
178.58quote price arrow down-2.21 (-1.22%)
Volume
11,280
Close
180.79quote price arrow down-5.34 (-2.87%)
Volume
2,978,762
52 week range
45.08 - 213.15

...

Loading . . .
  • Open188.33
  • Day High189.95
  • Day Low172.72
  • Prev Close186.13
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap43,664.40M
  • Shares Out241.52M
  • 10 Day Average Volume6.21M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change121.77

KEY STATS

  • Open188.33
  • Day High189.95
  • Day Low172.72
  • Prev Close186.13
  • 52 Week High213.15
  • 52 Week High Date05/04/21
  • 52 Week Low45.08
  • 52 Week Low Date05/14/20
  • Market Cap43,664.40M
  • Shares Out241.52M
  • 10 Day Average Volume6.21M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change121.77

RATIOS/PROFITABILITY

  • EPS (TTM)5.04
  • P/E (TTM)35.88
  • Fwd P/E (NTM)5.66
  • EBITDA (MRQ)2,030.26M
  • ROE (MRQ)80.65%
  • Revenue (MRQ)3,020.94M
  • Gross Margin (MRQ)88.55%
  • Net Margin (MRQ)47.81%
  • Debt To Equity (MRQ)26.07%

EVENTS

  • Earnings Date08/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
373.45+0.61+0.16%
SGEN
Seagen Inc
144.71-0.06-0.04%
MRNA
Moderna Inc
149.87-2.81-1.84%
GMAB
Genmab A/S
36.70+0.37+1.02%
INCY
Incyte Corp
83.23+0.86+1.04%